新型PT (II) 综合体具有抗癌活性,对胰腺管道腺癌细胞具有抗癌作用
Erika Stefàno1, Gianluca Rovito1, Luca G Cossa1
1Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Via Monteroni I-73100, Italy.
Bioinorganic chemistry and applications
|January 31, 2025
概括
新的 (II) 复合物显示出对抗胰腺癌的前景. 这些化合物,Pt-EtORSOphen (1和2),有效地抑制BxPC-3细胞生长,并可能针对线粒体进行增强的抗癌疗法.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 生物化学 生物化学
背景情况:
- 胰腺管道腺癌 (PDAC) 是一种具有越来越多发病率的侵袭性癌症.
- 西斯 (CDDP) 是一种基于的化疗药物,有效治疗各种癌症,包括PDAC.
- 耐药性需要开发新的抗癌药物,特别是基于的化合物,具有增强的DNA破坏能力.
研究的目的:
- 评估两种新型Pt (II) 阴性复合物Pt-EtORSOphen (1和2) 对BxPC-3 PDAC细胞的抗癌潜力.
- 为了比较这些新复杂物与西斯丁 (CDDP) 的疗效.
- 研究基链长度和脂性对Pt (II) 复合物的抗癌活性和细胞效应的影响.
主要方法:
- 两个Pt (II) 阴离子复合物的合成和表征:[Pt(η1-C2H4ROMe) ((DMSO) ((phen) ]+ (1) 和[Pt(η1-C2H4REt) ((DMSO) ((phen) ]+ (2).
- 在体外评估复合体1,2,CDDP对BxPC-3 PDAC细胞的抗增殖活性.
- 评估治疗细胞中的线粒体膜潜力 (ΔΨM) 损失,以确定作用机制.
主要成果:
- 两种Pt-EtORSOphen复合物 (1和2) 都显著抑制了BxPC-3 PDAC细胞生长.
- 复合物1和2的抗癌疗效与西斯丁 (CDDP) 的抗癌疗效相当.
- 基链长度和脂性没有显著改变抗癌效应,但影响了线粒体膜潜在损失的速度.
结论:
- Pt-EtORSOphen复合物 (1和2) 对BxPC-3 PDAC细胞有效,为西斯替代品提供了潜在的替代品.
- 这些复合物可以作为针对线粒体的脂类离子,用于抗癌疗法.
- 对它们的机制和治疗潜力的进一步研究是有必要的.
更多相关视频
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
13.9K
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
709
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
